Novo Nordisk shares dropped 4% after ending partnership with Hims & Hers, accused of deceptive marketing

From Yahoo Finance: 2025-06-25 15:09:00

Shares in Novo Nordisk dropped 4% following the termination of its partnership with Hims & Hers. Novo Nordisk accused Hims & Hers of breaching laws and disseminating deceptive marketing. Hims & Hers CEO, Andrew Dudum, refuted the claims, stating Novo Nordisk pressured them to promote Wegovy. Despite competition from Eli Lilly’s Zepbound, Wegovy sales grew by 85% in the first quarter. Investors should note Novo Nordisk wasn’t among the 10 best stocks identified by the Motley Fool Stock Advisor team. The top 10 list has historically outperformed the market significantly.



Read more at Yahoo Finance: Why Shares in Novo Nordisk Lost Weight Today